Compare CCAP & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCAP | BVS |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 250 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.7M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | CCAP | BVS |
|---|---|---|
| Price | $13.10 | $9.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $15.93 | $14.00 |
| AVG Volume (30 Days) | 193.5K | ★ 410.7K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | ★ 13.27% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $14.18 | $28.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.80 | $5.81 |
| 52 Week High | $16.50 | $9.53 |
| Indicator | CCAP | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 69.02 |
| Support Level | $12.56 | $8.43 |
| Resistance Level | $13.48 | N/A |
| Average True Range (ATR) | 0.33 | 0.35 |
| MACD | 0.08 | 0.05 |
| Stochastic Oscillator | 97.33 | 100.00 |
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.